Published in Gene Therapy Weekly, February 27th, 1995
In previous studies researcher Kandasamy Hariharan and colleagues demonstrated that different anti-gp120 antibodies bearing unique idiotypes (ID+ Abs) isolated by a panel of anti-Id MAbs exhibit unique epitope specificity and neutralizing activity.
"This approach enabled us to analyze different neutralizing epitopes on gp120 and the cross-reactive anti-gp120 antibodies in two HIV-1 infected individuals," they wrote ("Analysis of B Cell Repertoire Specific to the Neutralizing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.